Summary

G-protein coupled receptors, also known as seven-(pass)-transmembrane receptors, are a type of membrane receptor located in the cell membrane. Their primary function is to bind extracellular chemicals and transmit signals from these substances to intracellular molecules. Representing the largest family of membrane proteins, GPCRs play a pivotal role in mediating cellular responses to hormones and neurotransmitters. They are responsible for functions such as vision, olfaction, and taste.

The main offerings associated with G-protein-coupled receptors include cell lines, detection kits, cell culture reagents, and ligands. A cell line refers to a selected uniform cell culture derived from a population of cells typically sourced from a homogeneous tissue. Various types of assays, including camp functional assays, calcium functional assays, β-arrestin functional assays, radioligand binding and GTPγS functional assays, internalization assays, and trafficking assays, are employed in diverse applications. These applications span areas such as cancer research, CNS research, metabolic research, cardiovascular research, inflammation research, respiratory research, and others.

The G-protein-coupled receptors market research report is one of a series of new reports from The Business Research Company that provides G-protein-coupled receptors market statistics, including the G-protein-coupled receptors industry global market size, regional shares, competitors with a G-protein-coupled receptors market share, detailed G-protein-coupled receptors market segments, G-protein-coupled receptors market trends, and opportunities, and any further data you may need to thrive in the G-protein-coupled receptors industry. This G-protein-coupled receptors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The g-protein coupled receptors market size has grown strongly in recent years. It will grow from $2.97 billion in 2023 to $3.18 billion in 2024 at a compound annual growth rate (CAGR) of 7.1%. The expansion observed in the historical period can be credited to progress in drug discovery, FDA approvals, genomic breakthroughs, the emergence of new markets, consolidation within the market, and the increasing aging population.

The g-protein coupled receptors market size is expected to see strong growth in the next few years. It will grow to $4.09 billion in 2028 at a compound annual growth rate (CAGR) of 6.5%. The anticipated expansion in the forecast period can be ascribed to personalized medicine, heightened emphasis on rare diseases, the integration of artificial intelligence in drug discovery, drug development centered around patients, considerations of environmental and social factors, and the burgeoning biosimilar market. Noteworthy trends expected in the forecast period encompass progress in biotechnology, augmented investment in research and development, technological innovations, collaborative initiatives and partnerships, as well as the growth of digital therapeutics.

The anticipated increase in the prevalence of cancer is expected to drive the expansion of the G-protein-coupled receptors market in the future. Cancer, characterized by the uncontrolled spread of abnormal cells, can invade surrounding tissues and utilize the lymphatic and vascular systems for dissemination. GPCRs play a crucial role in processes associated with cancer, such as proliferative signaling, replicative immortality, evasion of growth suppressors, resistance to apoptosis, and the activation of invasion and metastasis. For instance, in March 2023, the American Society of Clinical Oncology (ASCO) reported that 81,800 individuals in the United States are expected to be diagnosed with kidney cancer in 2023. Additionally, breast cancer surpassed lung cancer as the most commonly diagnosed cancer globally in April 2022, affecting an estimated 2.3 million women in 2021 alone, as per the Breast Cancer Research Foundation. In the United States, where breast cancer has been the most prevalent for years, 281,550 women are projected to be diagnosed in 2021. Consequently, the increasing prevalence of cancer is a key driver for the growth of the G-protein-coupled receptors market.

Rising healthcare expenditures are poised to fuel the expansion of the g-protein-coupled receptors (GPCR) market. Healthcare expenditures encompass the overall financial outlay on healthcare-related services, products, and activities over a specified period, be it at an individual, community, national, or global level. The surge in healthcare spending typically results in the proliferation of healthcare services and infrastructure. Consequently, there is an increased demand for drugs targeting GPCRs as healthcare providers seek advanced and innovative treatments to address a wide array of diseases and conditions. As an illustration of this trend, in May 2023, the Office for National Statistics, a reputable UK-based statistics authority, disclosed a notable uptick in healthcare spending in the United Kingdom. The report indicated a 9.4% nominal and 9.7% real-term increase in healthcare spending. In 2021, the total healthcare expenditure in the UK amounted to $367.25 billion (£280.7 billion), with pharmaceutical expenditure reaching $51.84 billion (£39.6 billion). Notably, preventive care spending surged to $45.93 billion (£35.1 billion) in 2021, more than doubling from the previous year. Thus, the escalating healthcare expenditure trajectory is anticipated to be a key driver for the g-protein-coupled receptors market, reflecting the growing emphasis on advanced therapeutic solutions within the healthcare landscape.

A prominent trend gaining traction in the G-protein-coupled receptor (GPCR) market is the strategic investment to advance GPCR screening and antibody development. Leading companies in the GPCR sector are actively seeking investments to propel the development of drugs and medication technologies associated with GPCR-related diseases. For example, in February 2023, LifeArc Ventures, a venture capital firm based in the UK, invested $16 million in Maxion Therapeutics, a UK-based drug discovery company. This investment aims to advance antibody development for previously untreatable ion channel and GPCR-driven disorders, leveraging the proprietary KnotBody technology for the development of antibody therapeutics targeting ion channels and GPCRs.

Major players in the G-protein-coupled receptor market are concentrating on the development of innovative assay kits to further therapeutic discovery related to GPCRs. Assay kits, comprised of reagents and materials for specific analytical procedures or tests, are pivotal in this pursuit. In January 2021, PerkinElmer Inc., a US-based healthcare corporation, introduced new assays, including the industry's first TR-FRET-based assay for GTP binding and kits for B-Arrestin 1, B-Arrestin 2, and AP2. These assays empower researchers to utilize preferred cell models, facilitating a better understanding of GPCRs' crucial role in disease through the study of interaction, expression, and potential modulation of intracellular proteins involved in GPCR signaling mechanisms.

In February 2021, Eurofins Scientific, a France-based bioanalytical testing company, acquired Beacon Discovery for an undisclosed amount. This acquisition broadens Eurofins Scientific's product portfolio, incorporating validated ADMET, in vitro pharmacology, and chemistry services for integrated drug discovery solutions. The move aligns with Eurofins' strategy to collaborate with the pharmaceutical industry, providing expertise, drug discovery experience, and a track record of success in facilitating the discovery and development of new therapeutics. Beacon Discovery, the US-based biotechnology company acquired by Eurofins Scientific, specializes in G-protein-coupled receptor (GPCR) research.

Major companies operating in the g-protein coupled receptors market report are Pfizer Inc., Roche Holding AG, AbbVie Inc., Bayer AG, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC, Danaher Corporation, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Merck KGaA, Boehringer Ingelheim, Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Thermo Fisher Scientific Inc., Perkin Elmer Inc., Qiagen N.V., Bio-Techne Corporation, Abcam PLC, Cara Therapeutics Inc., Sosei Heptares Ltd., Eurofins DiscoverX Corporation, Crinetics Pharmaceuticals Inc., Domain Therapeutics SA, Addex Pharmaceuticals Ltd., Escient Pharmaceuticals Inc., Structure Therapeutics, Septerna

North America was the largest region in the G-protein coupled receptors market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the g-protein coupled receptors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the g-protein coupled receptors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The G-protein-coupled receptors market consists of revenues earned by entities by providing GPCR screening and profiling services, GPCR antibodies and immunoassays, hormones visual control. The market value includes the value of related goods sold by the service provider or included within the service offering. The G-protein-coupled receptors market also includes sales of adenosine, serotonin, and metabotropic receptor. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

ページTOPに戻る

Table of Contents

1. Executive Summary
2. G-Protein Coupled Receptors Market Characteristics
3. G-Protein Coupled Receptors Market Trends And Strategies
4. G-Protein Coupled Receptors Market - Macro Economic Scenario
4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market
5. Global G-Protein Coupled Receptors Market Size and Growth
5.1. Global G-Protein Coupled Receptors Market Drivers and Restraints
5.1.1. Drivers Of The Market
5.1.2. Restraints Of The Market
5.2. Global G-Protein Coupled Receptors Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global G-Protein Coupled Receptors Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)
6. G-Protein Coupled Receptors Market Segmentation
6.1. Global G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Cell Lines
Detection Kits
Cell Culture Reagents
Ligands
6.2. Global G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
CAMP Functional Assays
Calcium Functional Assays
β-Arrestin Functional Assays
Radioligand Binding and GTPγS Functional Assays
Internalization Assays
Trafficking Assays
6.3. Global G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Cancer Research
CNS Research
Metabolic Research
Cardiovascular Research
Inflammation Research
Respiratory Research
Other Applications
7. G-Protein Coupled Receptors Market Regional And Country Analysis
7.1. Global G-Protein Coupled Receptors Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global G-Protein Coupled Receptors Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific G-Protein Coupled Receptors Market
8.1. Asia-Pacific G-Protein Coupled Receptors Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China G-Protein Coupled Receptors Market
9.1. China G-Protein Coupled Receptors Market Overview
9.2. China G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India G-Protein Coupled Receptors Market
10.1. India G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan G-Protein Coupled Receptors Market
11.1. Japan G-Protein Coupled Receptors Market Overview
11.2. Japan G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia G-Protein Coupled Receptors Market
12.1. Australia G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia G-Protein Coupled Receptors Market
13.1. Indonesia G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea G-Protein Coupled Receptors Market
14.1. South Korea G-Protein Coupled Receptors Market Overview
14.2. South Korea G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe G-Protein Coupled Receptors Market
15.1. Western Europe G-Protein Coupled Receptors Market Overview
15.2. Western Europe G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK G-Protein Coupled Receptors Market
16.1. UK G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany G-Protein Coupled Receptors Market
17.1. Germany G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France G-Protein Coupled Receptors Market
18.1. France G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy G-Protein Coupled Receptors Market
19.1. Italy G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain G-Protein Coupled Receptors Market
20.1. Spain G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe G-Protein Coupled Receptors Market
21.1. Eastern Europe G-Protein Coupled Receptors Market Overview
21.2. Eastern Europe G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia G-Protein Coupled Receptors Market
22.1. Russia G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America G-Protein Coupled Receptors Market
23.1. North America G-Protein Coupled Receptors Market Overview
23.2. North America G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA G-Protein Coupled Receptors Market
24.1. USA G-Protein Coupled Receptors Market Overview
24.2. USA G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada G-Protein Coupled Receptors Market
25.1. Canada G-Protein Coupled Receptors Market Overview
25.2. Canada G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America G-Protein Coupled Receptors Market
26.1. South America G-Protein Coupled Receptors Market Overview
26.2. South America G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil G-Protein Coupled Receptors Market
27.1. Brazil G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East G-Protein Coupled Receptors Market
28.1. Middle East G-Protein Coupled Receptors Market Overview
28.2. Middle East G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa G-Protein Coupled Receptors Market
29.1. Africa G-Protein Coupled Receptors Market Overview
29.2. Africa G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. G-Protein Coupled Receptors Market Competitive Landscape And Company Profiles
30.1. G-Protein Coupled Receptors Market Competitive Landscape
30.2. G-Protein Coupled Receptors Market Company Profiles
30.2.1. Pfizer Inc.
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Roche Holding AG
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. AbbVie Inc.
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Bayer AG
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Novartis International AG
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. G-Protein Coupled Receptors Market Other Major And Innovative Companies
31.1. Sanofi SA
31.2. Bristol-Myers Squibb Company
31.3. AstraZeneca Plc
31.4. GlaxoSmithKline Plc
31.5. Danaher Corporation
31.6. Takeda Pharmaceutical Company Limited
31.7. Eli Lilly and Company
31.8. Merck KGaA
31.9. Boehringer Ingelheim
31.10. Teva Pharmaceutical Industries Ltd.
31.11. Daiichi Sankyo Company Limited
31.12. Thermo Fisher Scientific Inc.
31.13. Perkin Elmer Inc.
31.14. Qiagen N.V.
31.15. Bio-Techne Corporation
32. Global G-Protein Coupled Receptors Market Competitive Benchmarking
33. Global G-Protein Coupled Receptors Market Competitive Dashboard
34. Key Mergers And Acquisitions In The G-Protein Coupled Receptors Market
35. G-Protein Coupled Receptors Market Future Outlook and Potential Analysis
35.1 G-Protein Coupled Receptors Market In 2028 - Countries Offering Most New Opportunities
35.2 G-Protein Coupled Receptors Market In 2028 - Segments Offering Most New Opportunities
35.3 G-Protein Coupled Receptors Market In 2028 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer